Linklaters advises La Caisse (formerly CDPQ) in exclusive negotiations regarding Warburg Pincus’s proposed acquisition of a significant minority stake in Sebia.

Linklaters has advised La Caisse (formerly CDPQ), as an existing shareholder, in connection with entering into exclusive negotiations with Warburg Pincus for the proposed acquisition by the latter of a significant minority stake in Sebia, a global leader in In Vitro Diagnostics.

Existing shareholders, La Caisse, CVC Capital Partners Plc and Téthys Invest SAS, will remain significant shareholders in Sebia following completion of the transaction.

Execution of the proposed transaction remains subject to the finalisation of definitive documentation, completion of applicable employee consultation processes, and receipt of customary regulatory approvals. Closing is expected to occur no earlier than Q1 2026.

The Linklaters team was led by Florent Mazeron, Partner, and Julien Bourmaud-Danto, Partner, with Mathilde Gruaz, Associate in Corporate/M&A.
The team also included Cyril Boussion, Partner, Leïla Megdoud, Counsel, Wassim Mokadem, and Nicolas Le Guernic, Associates in Tax law. 
Pierre Zelenko, Partner, Antoine Réco and Tanguy Laurioz, Associates, advised on antitrust and foreign investment matters.